Les anticorps monoclonaux spécifiques de la COVID-19, fabriqués en laboratoire, sont-ils efficaces dans la prévention contre la COVID-19 ? https://t.co/A5ZmEUBCgK

RT @CochraneJapan: 人工のCOVID-19特異的モノクローナル抗体は、成人におけるCOVID-19の予防に有効か？ https://t.co/1ghJvjJUd5

人工のCOVID-19特異的モノクローナル抗体は、成人におけるCOVID-19の予防に有効か？ https://t.co/1ghJvjJUd5

@macroliter @kallmemeg https://t.co/B8ZBRf39Ub

RT @alfonso_casi: Atc monoclonales neutralizantes SARS‐CoV‐2 para prevenir la covid‐19: Para profilaxis preexposición, disminución de sínto…

Atc monoclonales neutralizantes SARS‐CoV‐2 para prevenir la covid‐19: Para profilaxis preexposición, disminución de síntomas clínicos de covid‐19 (certeza alta), de infección por SARS‐CoV‐2 (moderada) e ingreso hospital (baja) con tixagevimab/cilgavimab...

RT @COVID_Evidence: PubMed: SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19: BACKGROUND: Monoclonal antibodies (mAbs) ar…

RT @COVID_Evidence: PubMed: SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19: BACKGROUND: Monoclonal antibodies (mAbs) ar…

PubMed: SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19: BACKGROUND: Monoclonal antibodies (mAbs) are laboratory-produced molecules derived from the B cells of an infected host. They are being… https://t.co/IGQfZZlgqb #covid19 #SARSCOV2

SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19 https://t.co/LCmG50HtjL

Are laboratory-made COVID-19-specific monoclonal antibodies effective to prevent COVID-19 in adults? | Cochrane https://t.co/uWp1WSGe0q